Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial - Mulleners, WM; Kim, B-K; Láinez, MJA; Lanteri-Minet, M; Pozo-Rosich, P; Wang, S (Lancet Neurol, 2020)